TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ ४.३१
arrow_downward
-०.९२%(-०.०४०) 1D
US$ ४.३१
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$ ४.३१
High
US$ ४.४३
Low
US$ ४.१७
Mkt. cap
२८.२६ करोड
Avg. vol.
२.८९ लाख
Volume
२.३३ लाख
52-wk high
US$ ५.४३
52-wk low
US$ १.१७
EPS
-US$ ०.८६
Beta
१.५९
Shares outstanding
६.५६ करोड
No. of employees
४५०
Open
US$ ४.३१
High
US$ ४.४३
Low
US$ ४.१७
Mkt. cap
२८.२६ करोड
Avg. vol.
२.८९ लाख
Volume
२.३३ लाख
52-wk high
US$ ५.४३
52-wk low
US$ १.१७
EPS
-US$ ०.८६
Beta
१.५९
Shares outstanding
६.५६ करोड
No. of employees
४५०
News stories
From web sources and news partners
Decatur Daily
·
३८ मिनेट पहिले
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
Nacionale
·
२ घण्टा पहिले
Will the S&P 500 end 2026 down for the year? It's about 65 points above zero with 27 trading days left
Honolulu Star-Advertiser
·
८ घण्टा पहिले
Wall Street rout pushes S&P 500, Dow into correction
BigGo Finance
·
४३ मिनेट पहिले
S&P 500 Falls for Seventh Straight Session, Enters Correction as AI Stock Rally Loses Steam
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc